PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.\', \'Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.\', \'Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan.\', \'PharmaEssentia Corporation, Taipei, Taiwan.\', \'International Ph.D. Program for Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.\', \'Division of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.\', \'Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.\', \'Division of Pulmonary Medicine, Department of Internal Medicine, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan. pohao.feng@gmail.com.\', \'Division of Pulmonary Medicine, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, No. 291, Zhongzheng Rd., Zhonghe District, New Taipei City, 23561, Taiwan. pohao.feng@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s12325-021-01998-y
?:doi
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 34910280
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
?:title
  • Clinical Experience with Ropeginterferon Alfa-2b in the Off-Label Use for the Treatment of COVID-19 Patients in Taiwan.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all